Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Rocky9 who wrote (9743)	10/16/2006 1:42:37 PM
From: kenhott	Respond to of 10280

Thanks for the update. Someone should tell Goldman Sachs the trend is up.

To: Rocky9 who wrote (9743)	10/16/2006 4:10:41 PM
From: Biomaven	Read Replies (1) \| Respond to of 10280

That's a decent trajectory for Lunesta over the last several weeks. But is this because of the "free 7 days" coupon? (Although I think Ambien CR has had something similar on offer as well). Peter

To: Rocky9 who wrote (9743)	10/23/2006 2:40:31 PM
From: Iamarangerboy	Read Replies (1) \| Respond to of 10280

Is the fall off in price today due to decrease in the scrip up trend.... any word, Rocky???

To: Rocky9 who wrote (9743)	10/23/2006 7:41:47 PM
From: Robohogs	Read Replies (1) \| Respond to of 10280

Lunesta 81,387 new (down 0.7% WoW) Lunesta 134,958 tot (down 1.8% WoW) Xop MDI 21,029 new (up 1.7% WoW) Xop MDI 26,328 (down 0.1% WoW) Xop 34,555 new (up 6.7% YoY) Xop 49,917 tot (up 4.0% YoY) Mkt shares for Lunesta were up about 0.3%. Xop MDI shares were up 0.1-0.2% reversing decline from a month + ago. What is happening in MDI mkt is that Xop is now ahead of Proventil HFA, so gaining share in HFA space while HFA space very slowly gains share vs. the generic CFC space. Jon PS This was a "holiday" week of Columbus Day and most drugs were down 2-5% with Copaxone up along with a handful of other small drugs.